{"id":150826,"date":"2026-05-08T16:46:49","date_gmt":"2026-05-09T00:46:49","guid":{"rendered":"https:\/\/xira.com\/p\/?p=150826"},"modified":"2026-05-08T16:46:49","modified_gmt":"2026-05-09T00:46:49","slug":"c-r-bard-wins-defense-verdict-in-first-bellwether-trial-over-powerport-device","status":"publish","type":"post","link":"https:\/\/xira.com\/p\/2026\/05\/08\/c-r-bard-wins-defense-verdict-in-first-bellwether-trial-over-powerport-device\/","title":{"rendered":"C.R. Bard Wins Defense Verdict in First Bellwether Trial Over PowerPort Device"},"content":{"rendered":"<p>The trial, which began on April 21, is the first of about 3,000 cases in multidistrict litigation alleging Bard&#8217;s PowerPort devices are defective, leading to blood infections, thrombosis or fractures.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" align=\"left\" border=\"0\" height=\"1\" width=\"1\" alt=\"\" hspace=\"0\" src=\"https:\/\/feeds.feedblitz.com\/~\/i\/955584293\/0\/law\/legal-news\" title=\"\"><\/p>\n<div><a title=\"Add to FaceBook\" href=\"https:\/\/feeds.feedblitz.com\/_\/2\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/fbshare20.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Like on Facebook\" href=\"https:\/\/feeds.feedblitz.com\/_\/28\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/fblike20.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Pin it!\" href=\"https:\/\/feeds.feedblitz.com\/_\/29\/955584293\/law\/legal-news,https%3A%2F%2Fk2-prod-alm.s3.us-east-1.amazonaws.com%2Fbrightspot%2F1e%2Fc5%2F3dbd4605477893b3d81b4821d220%2Fbecton-dickinson-jpg767x505.jpg\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/pinterest20.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Stumble This\" href=\"https:\/\/feeds.feedblitz.com\/_\/12\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/stumble20.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Post to X.com\" href=\"https:\/\/feeds.feedblitz.com\/_\/24\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/x.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Subscribe by RSS\" href=\"https:\/\/feeds.feedblitz.com\/_\/20\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/rss20.png\" alt=\"\" title=\"\"><\/a>\u00a0\u00a0<\/div>\n<p>The trial, which began on April 21, is the first of about 3,000 cases in multidistrict litigation alleging Bard&#8217;s PowerPort devices are defective, leading to blood infections, thrombosis or fractures.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" align=\"left\" border=\"0\" height=\"1\" width=\"1\" alt=\"\" hspace=\"0\" src=\"https:\/\/feeds.feedblitz.com\/~\/i\/955584293\/0\/law\/legal-news\" title=\"\"><\/p>\n<div><a title=\"Add to FaceBook\" href=\"https:\/\/feeds.feedblitz.com\/_\/2\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/fbshare20.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Like on Facebook\" href=\"https:\/\/feeds.feedblitz.com\/_\/28\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/fblike20.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Pin it!\" href=\"https:\/\/feeds.feedblitz.com\/_\/29\/955584293\/law\/legal-news,https%3A%2F%2Fk2-prod-alm.s3.us-east-1.amazonaws.com%2Fbrightspot%2F1e%2Fc5%2F3dbd4605477893b3d81b4821d220%2Fbecton-dickinson-jpg767x505.jpg\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/pinterest20.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Stumble This\" href=\"https:\/\/feeds.feedblitz.com\/_\/12\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/stumble20.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Post to X.com\" href=\"https:\/\/feeds.feedblitz.com\/_\/24\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/x.png\" alt=\"\" title=\"\"><\/a>\u00a0<a title=\"Subscribe by RSS\" href=\"https:\/\/feeds.feedblitz.com\/_\/20\/955584293\/law\/legal-news\" rel=\"nofollow noopener\" target=\"_blank\"><img decoding=\"async\" height=\"20\" src=\"https:\/\/assets.feedblitz.com\/i\/rss20.png\" alt=\"\" title=\"\"><\/a>\u00a0\u00a0<\/div>\n","protected":false},"excerpt":{"rendered":"<p>The trial, which began on April 21, is the first of about 3,000 cases in multidistrict litigation alleging Bard&#8217;s PowerPort devices are defective, leading to blood infections, thrombosis or fractures. \u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 The trial, which began on April 21, is the first of about 3,000 cases in multidistrict litigation alleging Bard&#8217;s PowerPort devices are defective, leading [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":150827,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[23],"tags":[],"class_list":["post-150826","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-law-com"],"_links":{"self":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/150826","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/comments?post=150826"}],"version-history":[{"count":0,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/posts\/150826\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media\/150827"}],"wp:attachment":[{"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/media?parent=150826"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/categories?post=150826"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/xira.com\/p\/wp-json\/wp\/v2\/tags?post=150826"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}